异基因细胞用英语怎么说,异基因细胞的英文翻译


词语导航

基本信息

词语:异基因细胞

繁体:異基因細胞

拼音:yì jī yīn xì bāo

英语翻译

【医】 heterogenote

分词翻译

异的英语翻译:

different; other; separate; strange; surprise
【计】 exclusive-OR
【医】 allotrio-; heter-; hetero-; pecilo-; poecil-; poikilo-

基因的英语翻译:

gene
【化】 gene
【医】 efficient cause; essential cause; gen; gene; unit

细胞的英语翻译:

cell; matrix
【化】 cell
【医】 bioplast; cell; cella; cello-; cellula; cellulae; cellule; corpuscle
corpuscula; corpusculum; cyto-; kyto-; protoplast

翻译例句

1. 自体、同胎及同种异体或同种异基因细胞均可作为组织工程骨可靠的细胞来源,单纯异种成骨细胞不能作为组织工程骨的细胞来源。

Autogenous, homogenous, allograft or allogeneic cell could be used in bone tissue engineering, whereas heterogenous cell could not be used in bone tissue engineering.

2. 本文综述精原细胞异基因移植研究进展,并对该技术在今后临床应用中所存在的问题进行讨论。

In this article we reviewed the recent advances in xenogeneic transplantation of spermatogonial stem cell and also analyzed the potential problems existing in its clinical application.

3. 结论:异基因非清髓性外周血干细胞移植可选择性地应用于晚期乳腺癌的治疗。

Conclusion: Allogeneic peripheral blood stem cell non-myeloablative transplantation can be selectively used in the treatment of metastasis breast cancer.

4. 非去髓性异基因干细胞移植(nst)患者通常在移植后每月输注1次,连续1 ~4次。

Post non myeloablative allogeneic stem cell transplantation (NST) patients usually received DLI one times a month, consecutively 1 ~ 4 times.

5. 目的交流伴多种高危因素的非血缘异基因外周血干细胞移植(URD - PBSCT)经验。

Objective to communicate the experience of unrelated-donor peripheral blood stem cell transplantation (URD-PBSCT) for acute lymphoblastic leukemia (ALL) patient with multiple high disk factors.

6. 然而在进行异基因脏器移植时,首先遇到的最大障碍就是难以寻找到一个白细胞抗原(HLA)完全相匹配的适宜供体。

However, when allogeneic organ transplantation is performed, the biggest barrier to be overcomed is to select a suitable donor whose HLA is fully matched with the recipient.

7. 目的:观察异基因脾细胞经门静脉途径输注诱导受体免疫耐受的效果,以及联合使用塞尼哌后的效果。

Objective: to study the effects of immunological tolerance induced by administration of allogeneic splenocytes through portal vein in rats in combination with Daclizumab.

8. 探讨了护理因素对异基因造血干细胞移植中abo血型主要不合和次要不合的干细胞输注的影响。

The nursing factors are detected which infect allogeneic peripheral blood haematopoietic stem cell infusion in ABO-major incompatible transplantation or ABO-minor incompatible transplantation.

9. 目的确保重庆市首例非血缘异基因外周血干细胞移植(URD - PBSCT)治疗慢性粒细胞白血病成功。

Objective To insure success of unrelated-donor peripheral blood stem cell transplantation (URD-PBSCT) for patient with CML at the first time in chongqing.

10. 对200例异基因外周血造血干细胞移植患者护理措施进行总结和分析。

To summary and analyze the nursing methods of 200 patients received the allogeneic peripheral blood stem cell transplantation.

11. 目的探讨TJU103对小鼠同种异基因造血干细胞移植模型移植物抗宿主病(GVHD)是否起预防作用。

Objective To explore the role of TJU103 in preventing graft-versus-host disease (GVHD) after allogeneic stem cell transplantation in mice.

12. 用角质形成细胞和PDGF基因传染的成纤维细胞在无细胞异种?。

The composite skins are constructed with cultured keratinocytes and fibroblasts with PDGF gene on acellular xenodermis.

13. 异基因外周血干细胞移植中的GVHD比骨髓移植更严重吗?

Is the GVHD more severe in the allogeneic peripheral blood stem cell transplantation compared with allogeneic bone marrow transplantation?www.WENtiyI.com

14. 结论更昔洛韦防治异基因造血干细胞移植术后CMV感染效果良好,早期诊断和治疗更为重要。

Conclusion: GCVshows good effect on prevention and treatment of CMV infection after allo-BMT, and an early diagnoses and early treatment is more important.

15. 结论TJU103不仅可以显著抑制体外t淋巴细胞增殖效应,而且可显著降低小鼠同种异基因造血干细胞移植模型GVHD的发生率。

Conclusion TJU103 is capable of markedly inhibiting t cell proliferative response in vitro and can decrease GVHD incidence after allogeneic stem cell transplantation in mice.

16. 目的提高对异基因造血干细胞移植后早期深部真菌感染风险的认识。

Objective To understand the risk of invasive fungal infection at phase of preengraft- ment of allogeneic hematopoietic stem cell transplantation(HSCT).

17. 目的:对ABO血型不合的异基因造血干细胞移植患者输血状况及血液成分选择进行探讨。

Objective: To explore the blood component selection and transfusion for patients undergoing major ABO incompatible allogenic stem cell transplantation.

18. 研究领域的重要性:侵袭性真菌疾病(IFD)是实体器官或异基因干细胞移植术后接受免疫抑制治疗患者的严重并发症。

IMPORTANCE OF THE FIELD: Invasive fungal diseases (IFD) are severe complications in patients receiving immunosuppression after solid organ or allogeneic stem cell transplantation.

19. 目的探讨异基因造血干细胞移植(HSCT)后表现在肾脏的慢性移植物抗宿主病(GVHD)的临床及病理特点。

Objective to investigate the clinicopathologic characteristics of renal chronic graft versus host disease (GVHD) after allogeneic peripheral blood hematopoietic transplantation (HSCT).

20. 目的探讨非清髓异基因外周造血干细胞移植(NAST)在治疗高龄血液病中的作用。

Objective To study the role of nonmyeloablative allogeneic peripheral blood stem cell transplantation (NAST) in the treatment of hematological diseases in elderly patients.

21. 卡泊芬净一线治疗异基因造血干细胞移植患者侵袭性真菌病是有效且可耐受的。

Caspofungin first-line therapy was effective and well tolerated in allogeneic hematopoietic SCT patients with mycologically documented IA.

22. 目的探讨异基因外周血造血干细胞移植在肠型和极重度骨髓型放射病救治中的作用和地位。

Objective To explore the clinical significance of allogeneic peripheral stem cell transplantation in the treatment of acute radiation sickness.

23. 目的:研究同种异基因移植早期局部引流淋巴结和外周血t细胞的活化情况。

AIM: To study the activation of t cells from local lymph node and peripheral blood early after allotransplantation.

24. 对异基因外周血造血干细胞移植的猕猴,用Y特异性序列分析法和性别染色体检测法于移植后7及14天均检测到雄性供者嵌合。

Male donor chimerism were found on day 7 and 14 after allogeneic stem cell transplantation by Y-specific sequence and chromosome karyotype analysis.

25. 采用流式细胞术动态检测45例白血病患者异基因外周血干细胞移植前后人类白细胞抗原B27表达的变化。

Flow cytometry was used to detect the expression level of HLA-B27 in peripheral blood of 45 cases with leukemia after Allo-PBSCT.

26. 进行异基因和自体造血干细胞移植,在无血缘关系或家庭成员捐助者,以及各种疾病适应症的比例在不同国家和地区间差异很大。

Use of allogeneic or autologous HSCT, unrelated or family donors for allogeneic HSCT, and proportions of disease indications varied significantly between countries and regions.

27. 目的:探讨abo血型不合异基因外周血干细胞移植后纯红细胞再生障碍性贫血(PRCA)的治疗。

Objective: To explore the treatment of pure red cell aplasia (PRCA) after ABO-incompatible allogeneic peripheral blood stem cell transplantation.

28. 结论:NK细胞抑制小鼠异基因骨髓移植中的GVHD和移植排斥,促进骨髓植入及造血重建。

CONCLUSION: in mouse allogeneic bone marrow transplantation, alloreactivity NK cells prevents GVHD, reduces graft rejection, and promotes engraftment and reconstituting of hematopoiesis.

29. 结论:活化半相合混合骨髓移植方式可以降低GVHD反应,并与同基因和异基因脾细胞比例有关。

Conclusions: Halfmatched mixed BMT after activation could lower the GVHD reaction, which was relative to the ratio of syngeneic to allogeneic spleen cells.

30. 本研究旨在探讨非清髓异基因外周血造血干细胞移植(NAPBSCT)后造血嵌合体的临床意义。

The aim of this study was to analyze the hematopoietic chimerism after non-myeloablative allogeneic peripheral blood stem cell transplantation (NAPBSCT).

版权声明:问题易所有作品(图文、音视频)均来源网络,版权归原创作者所有,与本站立场无关,如不慎侵犯了你的权益,请联系我们告知,我们将做删除处理!